These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9306728)

  • 1. [Discovery and development of a novel immunosuppressant, tacrolimus hydrate].
    Tanaka H; Nakahara K; Hatanaka H; Inamura N; Kuroda A
    Yakugaku Zasshi; 1997 Aug; 117(8):542-54. PubMed ID: 9306728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunosuppressive activity of a microbial product].
    Hatanaka H; Shimomura K
    Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():69P-74P. PubMed ID: 9503409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK506 inhibits human lymphocyte migration and the production of lymphocyte chemotactic factors in liver allograft recipients.
    Adams DH; Liu Q
    Hepatology; 1996 Jun; 23(6):1476-83. PubMed ID: 8675167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK506 and the role of immunophilins in nerve regeneration.
    Gold BG
    Mol Neurobiol; 1997 Dec; 15(3):285-306. PubMed ID: 9457703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
    McDiarmid SV; Busuttil RW; Ascher NL; Burdick J; D'Alessandro AM; Esquivel C; Kalayoglu M; Klein AS; Marsh JW; Miller CM
    Transplantation; 1995 Feb; 59(4):530-6. PubMed ID: 7533345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology.
    Bierer BE; Holländer G; Fruman D; Burakoff SJ
    Curr Opin Immunol; 1993 Oct; 5(5):763-73. PubMed ID: 7694595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of FK506 on graft coronary disease of rat cardiac allograft--a comparison with cyclosporine.
    Arai S; Teramoto S; Senoo Y
    J Heart Lung Transplant; 1992; 11(4 Pt 1):757-62. PubMed ID: 1379829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of rapamycin in murine peripheral nerve isografts and allografts.
    Myckatyn TM; Ellis RA; Grand AG; Sen SK; Lowe JB; Hunter DA; Mackinnon SE
    Plast Reconstr Surg; 2002 Jun; 109(7):2405-17. PubMed ID: 12045568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
    Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ
    J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy in ocular diseases].
    Mochizuki M
    Nippon Ganka Gakkai Zasshi; 1992 Dec; 96(12):1608-34. PubMed ID: 1283052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
    Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
    Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK506 rescues peripheral nerve allografts in acute rejection.
    Feng FY; Ogden MA; Myckatyn TM; Grand AG; Jensen JN; Hunter DA; Mackinnon SE
    J Neurotrauma; 2001 Feb; 18(2):217-29. PubMed ID: 11229713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects.
    Wallemacq PE; Reding R
    Clin Chem; 1993 Nov; 39(11 Pt 1):2219-28. PubMed ID: 7693372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat.
    Nishi M; Herbort CP; Matsubara M; Morishita Y; Nishimura M; Nieda M; Mori S; Mochizuki M
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2477-86. PubMed ID: 7686893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
    Gruessner RW; Burke GW; Stratta R; Sollinger H; Benedetti E; Marsh C; Stock P; Boudreaux JP; Martin M; Drangstveit MB; Sutherland DE; Gruessner A
    Transplantation; 1996 Jan; 61(2):261-73. PubMed ID: 8600635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK506, an immunosuppressant targeting calcineurin function.
    Dumont FJ
    Curr Med Chem; 2000 Jul; 7(7):731-48. PubMed ID: 10702636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new immunosuppressant: tacrolimus.
    James DG
    Postgrad Med J; 1996 Oct; 72(852):586. PubMed ID: 8977938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive and slow-binding inhibition of calcineurin by drug x immunophilin complexes.
    Salowe SP; Hermes JD
    Arch Biochem Biophys; 1998 Jul; 355(2):165-74. PubMed ID: 9675023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506.
    Xu X; Su B; Barndt RJ; Chen H; Xin H; Yan G; Chen L; Cheng D; Heitman J; Zhuang Y; Fleischer S; Shou W
    Transplantation; 2002 Jun; 73(11):1835-8. PubMed ID: 12085010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined immunosuppression of FK506 and RS-61443 in rat limb allotransplantation].
    Kang H; Hong GX; Wang FB; Chen ZB; Huang QS; Weng YX
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 May; 17(3):264-7. PubMed ID: 12822367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.